03/12/2026
P.S.S. Urology has officially launched its Regulation D 506(c) raise.
We’re a profitable, nationally operating medtech company serving hospitals, surgery centers, and private practices across the U.S. Our focus is simple: reliable urology solutions, clear pricing, and a process that makes it easy for clinicians and administrators to work with us.
This raise is designed to scale what’s already working and support growing demand in key regions.
Interested accredited investors can learn more on our raise page.
https://investinpacificsurgical.com/
